Pillstats
Rx only · Injection, Powder, Lyophilized, For Solution · Intramuscular

Ziprasidone Mesylate

Brands: Geodon · Ziprasidone Mesylate

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US9 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)115698
US makers8 labelers
Packages11
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$6.91$13.83$20.74$27.66Dec 2025Apr 2026Jul 2026
$21.807
Latest avg · Jul 22, 2026
+17%
Since Dec 17, 2025
7
Active US suppliers
40%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

5951.2K1.8K2.4K2025 Q12025 Q22025 Q32025 Q42026 Q1
1.8K
Rx · 2026 Q1
2.9K
Units dispensed
+14%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Dr.Reddy's laboratories Limitedunknown2SUPPLYING
Fosun Pharma USA Incunknown2SUPPLYING
STERISCIENCE SPECIALTIES PRIVATE LIMITEDunknown2SUPPLYING
Gland Pharma Limitedunknown1SUPPLYING
Viatris Specialty LLCunknown1SUPPLYING
HF Acquisition Co LLC, DBA HealthFirstunknown1SUPPLYING
Novadoz Pharmaceuticals LLCunknown1SUPPLYING
Roerigunknown1EXITED 2026

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.